A 58-year-old female with type 2 diabetes presents with numbness and tingling in her feet, slow-healing sores, and a recent hemoglobin A1c level of 9.2%. Given these clinical findings, what is the most appropriate nursing intervention to prioritize in her care plan?

C) Advise the patient on proper foot care and schedule regular podiatry visits.

A) Educate the patient on maintaining tight glucose control to prevent further complications.

B) Refer the patient to a dietitian to develop a personalized nutrition plan.

C) Advise the patient on proper foot care and schedule regular podiatry visits.

D) Initiate a discussion about starting an SGLT2 inhibitor with the healthcare provider.

A patient with type 2 diabetes presents with numbness and tingling in her feet, slow-healing sores, and a hemoglobin A1c level of 9.2%. Which intervention should the nurse prioritize to address the patient's current complications and prevent further issues?

A) Initiate a referral to a podiatrist for specialized foot care.

B) Educate the patient on the importance of daily foot inspections.

C) Discuss with the healthcare provider the possibility of adding an SGLT2 inhibitor.

D) Schedule a consultation with a dietitian to optimize nutritional management.

A 60-year-old patient with type 2 diabetes mellitus is being evaluated for increased fatigue and mild shortness of breath on exertion, with recent findings of microalbuminuria and reduced hemoglobin A1c to 8.5%. Which intervention should the nurse prioritize to address both renal protection and potential anemia?

C) Discuss the initiation of an angiotensin-converting enzyme (ACE) inhibitor

A) Initiate erythropoietin therapy to address anemia

B) Encourage increased dietary iron intake and monitor hemoglobin levels

C) Discuss the initiation of an angiotensin-converting enzyme (ACE) inhibitor

D) Recommend increased diuretic use to manage fluid retention

A 65-year-old female patient with diabetes presents with mild anemia and early signs of heart failure with preserved ejection fraction (HFpEF). As part of the care plan, the healthcare team recommends starting low-dose ACE inhibitor therapy. Which nursing intervention is most important to implement when starting this medication?

A) Monitor the patient's blood pressure closely for hypotension.

B) Advise the patient to increase dietary potassium intake.

C) Assess the patient for signs of increased blood glucose levels.

D) Encourage the patient to reduce fluid intake drastically.

A patient with mild anemia, mild left ventricular hypertrophy, and slightly reduced ejection fraction is being managed with low-dose ACE inhibitors and lifestyle modifications. Which nursing intervention is most important to prioritize in this patient's care plan to address the risk of worsening heart failure symptoms?

A) Monitor daily weights and assess for signs of fluid overload.

B) Encourage increased dietary intake of iron-rich foods to improve anemia.

C) Schedule regular blood pressure checks to ensure ACE inhibitor effectiveness.

D) Educate the patient about the importance of medication adherence.

During a follow-up visit, a patient with diabetes and a history of heart failure reports occasional dizziness upon standing. Her blood pressure is 110/70 mmHg, and her serum creatinine has increased to 1.4 mg/dL. The healthcare team adjusted her ACE inhibitor dosage. What is the most appropriate nursing intervention to address the patient's dizziness?

B) Advise the patient to change positions slowly to avoid orthostatic hypotension.

A) Encourage the patient to increase her fluid intake to improve blood volume.

B) Advise the patient to change positions slowly to avoid orthostatic hypotension.

C) Suggest the patient discontinue the ACE inhibitor until her symptoms resolve.

D) Recommend increasing dietary sodium to help raise blood pressure.

A patient with a history of diabetes and heart failure is experiencing dizziness upon standing, and recent labs show a slight increase in serum creatinine. Which nursing intervention should be prioritized to address the patient's current symptoms and lab findings?

B) Adjust the patient's position slowly from sitting to standing to prevent orthostatic hypotension

A) Encourage the patient to increase fluid intake to address dehydration

B) Adjust the patient's position slowly from sitting to standing to prevent orthostatic hypotension

C) Initiate a high-protein diet to improve renal function

D) Increase the dosage of the patient's ACE inhibitor to enhance cardiac output

A patient with renal impairment shows signs of fluid retention and hypotension. Her ACE inhibitor dose was reduced, and she is experiencing edema and elevated BUN levels. What is the most appropriate nursing intervention to support the revised treatment plan?

B) Advise the patient to reduce dietary sodium to minimize fluid retention.

A) Encourage the patient to increase her fluid intake to promote renal perfusion.

B) Advise the patient to reduce dietary sodium to minimize fluid retention.

C) Suggest the patient to take an over-the-counter diuretic to manage edema.

D) Recommend the patient to monitor her blood pressure daily and report any significant decreases.

A patient with renal impairment is experiencing persistent hypotension and worsening renal function. What nursing intervention should be prioritized to address her condition?

B) Monitor daily weights and assess for signs of fluid overload.

A) Encourage increased fluid intake to help with kidney perfusion.

B) Monitor daily weights and assess for signs of fluid overload.

C) Increase dietary sodium to improve blood pressure.

D) Discontinue all antihypertensive medications immediately.

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: In diabetes, the body's ability to produce or effectively use insulin is impaired. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells leads to insufficient insulin production. In Type 2 diabetes, insulin resistance occurs, where cells do not respond adequately to insulin, often due to obesity and genetics.

• Secondary mechanism: Hyperglycemia results from inadequate insulin action, causing elevated blood glucose levels. This leads to osmotic diuresis, dehydration, and electrolyte imbalances, affecting multiple body systems.

• Key complication: Chronic hyperglycemia damages blood vessels, leading to microvascular complications like retinopathy, nephropathy, and neuropathy, and macrovascular complications such as cardiovascular disease and stroke, significantly impacting morbidity and mortality.

Patient Profile

Demographics:

58-year-old female, retired school teacher

History:

• Key past medical history: Type 2 diabetes diagnosed 10 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing numbness and tingling in feet

• Key symptoms: Fatigue, frequent urination, blurred vision, slow-healing sores

• Vital signs: Blood pressure 145/90 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 210 mg/dL

Section 1

After conducting an initial physical assessment, the healthcare team observed several key findings that indicated progression of the patient's diabetic complications. The numbness and tingling in her feet suggested diabetic neuropathy, a common microvascular complication. Additionally, the slow-healing sores on her lower extremities raised concerns about potential peripheral vascular disease and impaired wound healing, both of which are exacerbated by chronic hyperglycemia. A monofilament test confirmed decreased sensation in both feet, increasing her risk for foot ulcers and subsequent infections.

Laboratory results further revealed worsening control of her diabetes. Her hemoglobin A1c level was 9.2%, indicating poor long-term glucose control. Urinalysis showed microalbuminuria, suggesting early diabetic nephropathy, which necessitates closer monitoring and potential adjustments to her medication regimen. The combination of elevated blood pressure and hyperlipidemia further increased her risk for cardiovascular complications, a significant concern given her history.

Given these findings, the clinical team considered the need for a multidisciplinary approach to manage her complex condition. Adjustments to her medication regimen were discussed, including the potential addition of a sodium-glucose co-transporter-2 (SGLT2) inhibitor to improve glycemic control and provide renal protection. A referral to a podiatrist was also considered crucial for ongoing foot care, while a consultation with a dietitian would help in tailoring a nutrition plan to better manage her diabetes and cardiovascular risks. These steps aimed to prevent further complications and improve her overall quality of life.

Section 2

Following the implementation of the multidisciplinary plan, the patient returned for a follow-up appointment six weeks later. During this visit, the healthcare team performed a comprehensive assessment to evaluate her response to the interventions. The patient reported adherence to her new medication regimen, which included the addition of an SGLT2 inhibitor. She also attended sessions with the dietitian, who had developed a personalized nutrition plan focusing on balanced carbohydrates and heart-healthy fats. The podiatrist had been actively involved in her foot care, addressing existing sores and educating her on preventive measures.

Vital signs revealed a modest improvement in her blood pressure, now reading 138/82 mmHg, indicating a positive trend towards better cardiovascular health. Repeat laboratory tests showed a reduction in her hemoglobin A1c to 8.5%, suggesting better glycemic control, although still above the target goal. However, the urinalysis continued to show microalbuminuria, underscoring the need for ongoing renal monitoring and possibly further adjustments in her medication to protect kidney function. Despite these improvements, a new concern emerged: the patient reported increased fatigue and mild shortness of breath on exertion, raising suspicion for anemia or potential heart-related issues.

The clinical team recognized the importance of addressing these new symptoms promptly. Given the patient's history and current findings, further investigations were warranted. An echocardiogram was ordered to evaluate cardiac function, and a complete blood count was performed to assess for anemia. The team emphasized the importance of continued adherence to lifestyle modifications and medications, discussing the possibility of introducing angiotensin-converting enzyme (ACE) inhibitors for renal protection and blood pressure control. The patient's journey highlighted the need for vigilant monitoring and flexibility in her management plan to prevent the progression of diabetes-related complications and enhance her quality of life.

Section 3

During the subsequent follow-up visit, the healthcare team reviewed the new diagnostic results to explore the cause of the patient's increased fatigue and mild shortness of breath. The complete blood count revealed a hemoglobin level of 10.2 g/dL, indicative of mild anemia, possibly attributable to chronic disease or nutritional deficiencies. The echocardiogram provided more insight into her cardiac status, showing mild left ventricular hypertrophy and a slightly reduced ejection fraction at 50%, suggesting early signs of heart failure with preserved ejection fraction (HFpEF). These findings underscored the importance of a tailored management approach to address these emerging complications while continuing to support her glycemic control and renal function.

Given these new developments, the clinical team decided to implement several strategic changes to the patient's care plan. To address her anemia, they recommended a further evaluation of her iron levels, vitamin B12, and folate status, with the potential addition of supplements if deficiencies were identified. The team also initiated low-dose ACE inhibitor therapy, not only to improve her blood pressure and renal protection but also to potentially ameliorate her cardiac function. Concurrently, they emphasized the importance of ongoing lifestyle modifications, including a diet rich in iron and omega-3 fatty acids to support cardiovascular health, and increased physical activity as tolerated to improve her functional capacity.

The patient was encouraged to monitor her symptoms closely, particularly any worsening of fatigue or shortness of breath, and to report them promptly. The multidisciplinary team arranged for a follow-up in four weeks to reassess her response to the updated treatment regimen and to ensure that her hemoglobin levels and cardiac function were stabilizing. This proactive approach aimed to mitigate the progression of anemia and heart complications, reinforcing the need for continuous adaptation of her management plan to enhance her overall well-being and prevent further diabetes-related complications.

Section 4

Following the implementation of the updated care plan, the patient returned for her scheduled follow-up appointment. During the visit, the healthcare team conducted a comprehensive assessment to evaluate her response to the interventions. The patient reported a moderate improvement in her energy levels and a slight reduction in her shortness of breath. Her adherence to the prescribed dietary changes and increased physical activity was commendable, as she expressed motivation to continue these lifestyle modifications. However, she did note occasional episodes of dizziness, particularly when moving from a sitting to a standing position.

On examination, her vital signs indicated a blood pressure of 110/70 mmHg, slightly lower than her previous readings, which could explain the dizziness. Her heart rate was 78 beats per minute, regular, and her respiratory rate was 18 breaths per minute. Repeat laboratory tests revealed a hemoglobin level of 11.0 g/dL, showing a modest improvement from the previous result. Iron studies indicated borderline low ferritin levels, prompting the team to prescribe an oral iron supplement to further address her anemia. Additionally, a follow-up echocardiogram showed stable cardiac findings with no further decline in ejection fraction.

Despite these encouraging results, her renal function tests revealed a slight increase in serum creatinine to 1.4 mg/dL from 1.2 mg/dL, raising concerns about her renal status in the context of diabetes and ACE inhibitor therapy. This prompted the team to adjust her ACE inhibitor dosage and closely monitor her kidney function. The patient was advised to maintain adequate hydration and to continue monitoring her symptoms. The team scheduled another follow-up in four weeks to reassess her renal function and overall response to the modified treatment plan. This approach aimed to strike a balance between managing her cardiac and renal health while preventing further complications.

Section 5

Four weeks later, the patient returned for her follow-up appointment. She reported feeling more fatigued than usual, with persistent dizziness and new onset of mild swelling in her lower extremities, especially noticeable at the end of the day. During the examination, her blood pressure had dropped further to 105/68 mmHg, and her heart rate remained stable at 80 beats per minute. Her respiratory rate was also stable at 18 breaths per minute. A physical examination revealed 1+ pitting edema in her ankles, raising concern for potential fluid retention.

The repeat laboratory tests indicated further deterioration in her renal function, with serum creatinine levels rising to 1.6 mg/dL. Her glomerular filtration rate (GFR) had decreased slightly, suggesting a progression in her renal impairment. Additionally, her blood urea nitrogen (BUN) level was elevated at 30 mg/dL, indicating potential kidney stress. The patient’s hemoglobin remained stable at 11.0 g/dL, but her ferritin levels had not improved significantly despite the iron supplementation, suggesting a need for reevaluation of her anemia management strategy.

Given these findings, the healthcare team faced the challenge of adjusting her treatment plan to address the new complications. The persistent hypotension and renal function decline necessitated a cautious approach to her ACE inhibitor therapy. The team decided to further reduce the ACE inhibitor dose and evaluate the need for alternative antihypertensive medications that might be more renal-friendly. Additionally, they emphasized the importance of monitoring her fluid intake and dietary sodium, as these could impact her edema and renal function. The patient was scheduled for a follow-up appointment in two weeks to closely monitor her response to these adjustments and ensure timely intervention to prevent further deterioration.